Ironwood Pharmaceuticals reported $395.85M in Loan Capital for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
Agios Pharmaceuticals AGIO:US USD 1.06M 0
Alnylam Pharmaceuticals ALNY:US USD 1.02B 338.25M
Astellas Pharma 4503:JP JPY 82.39B 29.23B
AstraZeneca AZN:LN USD 23.68B 3.47B
Astrazeneca AZN:US USD 23.68B 3.47B
Charles River Laboratories CRL:US USD 2.94B 60.16M
Esperion Therapeutics ESPR:US USD 259.49M 407K
Exact Sciences EXAS:US USD 2.24B 2.38M
Halozyme Therapeutics HALO:US USD 1.49B 344.03M
Intercept Pharmaceuticals ICPT:US USD 222.86M 491M
Ironwood Pharmaceuticals IRWD:US USD 395.85M 399K
Karyopharm Therapeutics KPTI:US USD 302.89M 201K
Moderna Inc MRNA:US USD 922M 281M
Pacira Pharmaceuticals PCRX:US USD 714M 7.88M
Ptc Therapeutics PTCT:US USD 981.61M 165K
Sarepta Therapeutics SRPT:US USD 1.54B 441.9M
Takeda 4502:JP JPY 4.17T 151.94B